D3 PLATFORM
D3 Platform
The chemical focus of the CNPD3 is on unique natural products, and the goal is to fully exploit the biosynthetic and therapeutic potential of untapped biodiversity for drug discovery. Candidate compounds are investigated for further development through interactive chemistry and pharmacology efforts. The center embraces all aspects of natural products research from discovery, biosynthesis and chemical synthesis, assay development, screening and target identification to drug development.
CNPD3 FOCUS AND RESEARCH
CNPD3 FOCUS AND RESEARCH
Microbial Genomics & Synthetic Biology
CNPD3 FOCUS AND RESEARCH
Molecular Diversity and Screening
CNPD3 FOCUS AND RESEARCH
Molecular Pharmacology
CNPD3 FOCUS AND RESEARCH
AI-based and Structure-based Drug Design & Optimization
CNPD3 FOCUS AND RESEARCH
Synthetic Chemistry
CNPD3 Focus and Research
PROTAC & Targeted Therapeutics
CNPD3 FOCUS AND RESEARCH
Botanical Translational Science
CNPD3 FOCUS AND RESEARCH
Animal Models of Disease
A New Wave of MEDICINE
Dr. Hendrik Luesch
Answering the Call
In an ocean of possibilities, Dr. Hendrik Luesch is answering the call to make the next great drug discovery. His work takes him below the surface of the sea, where new medicines harbor hope for a healthier tomorrow.
save the date: 6th UF Drug Discovery Symposium
April 15-16, 2024
6th UF Drug Discovery Symposium
The registration deadline is April 5.
CNPD3 Seminar series
CNPD3 Seminar Series | Dr. Jon Clardy
Wednesday, February 21st 2024 from 10:00 AM to 11:00 AM in the Shands Auditorium 6120 Dr. Clardy’s presentation is titled “Bacterial Signals to Human Hosts”
CNPD3 Seminar Series | Dr. Bin T. Teh
Tuesday, February 6th 2024 from 12:00 PM to 1:00 PM in the Cancer & Genetics Research Complex, Auditorium 101 Dr. Teh’s presentation is titled “Biodiversity Medicine: A New Horizon and…
CNPD3 Seminar Series | Dr.Jason Crawford
Thursday January 25th 2024 from 10:00 AM – 11:00 AM in the Shands Auditorium 6120 Dr. Crawford’s presentation is entitled “Metabolism at the Human-Microbe Interface”
CNPD3 Seminar Series | Dr. Roger Linington
Wednesday, January 24th 2024 from 10:00 AM – 11:00 AM in Communicore C1-015 Dr. Linington’s presentation title is “Informatics-Based Approaches to Natural Products Discovery in an Age of Reisolation”
DEPARTMENT NEWS
UF College of Pharmacy secures No. 3 spot in latest Blue Ridge Institute research rankings
n 2023, the National Institutes of Health awarded almost $21.5 million to the UF College of Pharmacy.
Third International Kratom Symposium draws experts from across the globe
The symposium was held Feb. 14-15 in Orlando and featured over 20 presentations by esteemed scientists studying kratom.
Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics
Hendrik Luesch, Ph.D., and Yousong Ding, Ph.D., co-authored the study that identified the genes responsible for producing dolastatin 10.
Novel compound opens new avenue in immunotherapy treatment for cancers
Guangrong Zheng, Ph.D., a professor in the department of medicinal chemistry, was part of a research team thatdeveloped a first-of-its-kind compound that could open a new avenue for using immunotherapy…